2026

​

Kadeřábková, N., Furniss, RCD., Maslova, E., Potter, KE., Eisaiankhongi, L., Bernal, P., Filloux, P., Landeta, C., Gonzalez, D., McCarthy, RR., Mavridou, DAI. (2026). Antibiotic potentiation and inhibition of cross-resistance in pathogens associated with cystic fibrosis. eLife, 12:RP91082. DOI: 10.7554/eLife.91082

​

2025

​

Harper, S., Afonso, D., Watts, K., Doble, B., Eklund, O., Vadgama, S., ... & Taylor, M. (2025). Evaluating the Role and Policy Implications of Using External Evidence in Survival Extrapolations: A Case Study of Axicabtagene Ciloleucel Therapy for Second-Line DLBCL: S. Harper et al. PharmacoEconomics, 1-15.

​​

2024

​​​​

Willis, M., Nilsson, A., Kellerborg, K., Lwin, Z.M.T., Prelaj, A. (2024). Budget impact models for lung cancer interventions: A systematic literature review. Journal of Managed Care & Specialty Pharmacy, 30(9). DOI: 10.18553/jmcp.2024.30.9.1041

 

Lenz, T., Sirel, M., Hoppe, H., Shafeeq, S., Le Roch, K., Ribacke, U. (2024). Epigenetics and chromatin structure regulate var2csa expression and the placental binding phenotype in Plasmodium falciparum. eLife, 13:RP93632 DOI: 10.7554/eLife.93632.1

​

Löhr JM, Öhlund D, Söreskog E, Andersson E, Vujasinovic M, Zethraeus N, Sund M. Can our experience with surveillance for inherited pancreatic cancer help to identify early pancreatic cancer in the general population? Fam Cancer. 2024 Aug;23(3):399-403. doi: 10.1007/s10689-024-00363-6. 

​​

​

2023​

​

Norlin, J.M., Kellerborg, K., Persson, U., Åström, D.O., Hagell, P., Martinez-Martin, P., Odin, P. (2023). Clinical Impression of Severity Index for Parkinson's Disease and Its Association to Health-Related Quality of Life. Movement Disorders Clinical Practice, 10(3), 392-398. DOI: 10.1002/mdc3.13649 

​

Kadeřábková, N., Mahmood, A. J. S., Furniss, R. C. D., & Mavridou, D. A. I. (2023). Making a chink in their armor: Current and next-generation antimicrobial strategies against the bacterial cell envelope. Advances in microbial physiology, 83, 221–307. DOI: 10.1016/bs.ampbs.2023.05.003 

​

Loftager, A. S. L., Danø, A., Eklund, O., Vadgama, S., Hedlof Kanje, V., & Munk, E. (2023). Axicabtagene ciloleucel compared to standard of care in Swedish patients with large B-cell lymphoma: a cost-effectiveness analysis of the ZUMA-7 trial. Journal of Medical Economics, 26(1), 1303-1317.

​

​

2022

​

Edmondson-Jones, M., Dibbern, T., Hultberg, M., Anell, B., Medin, E., Feng, Y., & Talarico, C. (2022). Impact of pneumococcal conjugate vaccines on healthcare utilization and direct costs for otitis media in children≤ 2 years of age in two Swedish regions. Human Vaccines & Immunotherapeutics, 18(1), 1942712.

​

Söreskog, E., Jacobson, T., Kirketeig, T., Fritzell, P., Karlsten, R., Zethraeus, N., & Borgström, F. (2022). Impact of spinal cord stimulation on sick leave and disability pension in patients with chronic neuropathic pain: a real-world evidence study in Sweden. Pain, 10-1097.

​

Banefelt, J., Timoshanko, J., Söreskog, E., Ortsäter, G., Moayyeri, A., Åkesson, K. E., ... & Libanati, C. (2022). Total hip Bone mineral density as an indicator of fracture risk in bisphosphonate‐treated patients in a real‐world setting. Journal of Bone and Mineral Research, 37(1), 52-58.​​

​

Kellerborg, K., Norlin, J.M., Odin P. (2022). The Relationship between PDQ-8 and Costs in Parkinson's Disease-A Swedish Register-Based Study. Movement Disorders Clinical Practice, 10(2), 231–237. DOI:10.1002/mdc3.13630

 

Åström, DO., Simonsen, J., Raket, LL., Sgarbi, S., Hellsten, J., Hagell, P., Norlin, JM., Kellerborg, K., Martinez-Martin, P., Odin, P. (2022). High risk of developing dementia in Parkinson's disease: a Swedish registry-based study. Scientific Reports 12, 16759 (2022). DOI: 10.1038/s41598-022-21093-8

 

Raket, LL., Oudin Åström, D., Norlin, J.M., Kellerborg, K., Martinez-Martin, P., Odin, P. (2022). Impact of age at onset on symptom profiles, treatment characteristics and health-related quality of life in Parkinson's disease. Scientific Reports 12, 526 (2022). DOI: 10.1038/s41598-021-04356-8

​​

Kaderabkova, N., Bharathwaj, M., Furniss, R. C. D., Gonzalez, D., Palmer, T., & Mavridou, D. A. I. (2022). The biogenesis of β-lactamase enzymes. Microbiology (Reading, England), 168(8), 001217. DOI: 10.1099/mic.0.001217 

 

Furniss, R. C. D., Kaderabkova, N., Barker, D., Bernal, P., Maslova, E., Antwi, A. A. A., McNeil, H. E., Pugh, H. L., Dortet, L., Blair, J. M. A., Larrouy-Maumus, G., McCarthy, R. R., Gonzalez, D., & Mavridou, D. A. I. (2022). Breaking antimicrobial resistance by disrupting extracytoplasmic protein folding. eLife, 11, e57974. DOI: 10.7554/eLife.57974 

​

​

2021

​

Söreskog, E., Borgström, F., Lindberg, I., Ström, O., Willems, D., Libanati, C., ... & Charokopou, M. (2021). A novel economic framework to assess the cost-effectiveness of bone-forming agents in the prevention of fractures in patients with osteoporosis. Osteoporosis International, 32, 1301-1311.

ISO 690

​

Hagström, E., Sorio Vilela, F., Svensson, M. K., Hallberg, S., Söreskog, E., & Villa, G. (2021). Cardiovascular event rates after myocardial infarction or ischaemic stroke in patients with additional risk factors: a retrospective population-based cohort study. Advances in Therapy, 38, 4695-4708.

​

Söreskog, E., Lindberg, I., Kanis, J. A., Åkesson, K. E., Willems, D., Lorentzon, M., ... & Borgström, F. (2021). Cost-effectiveness of romosozumab for the treatment of postmenopausal women with severe osteoporosis at high risk of fracture in Sweden. Osteoporosis International, 32, 585-594.

​

Edmondson-Jones, M., Dibbern, T., Hultberg, M., Anell, B., Medin, E., Feng, Y., & Talarico, C. (2021). The effect of pneumococcal conjugate vaccines on otitis media from 2005 to 2013 in children aged≤ 5 years: a retrospective cohort study in two Swedish regions. Human Vaccines & Immunotherapeutics, 17(2), 517-526.​

​

Kellerborg, K., Wouterse, B., Brouwer, W., van Baal, P. (2021). Estimating the costs of non-medical consumption in life-years gained for economic evaluations. Social science & medicine (1982), 289, 114414. DOI: 10.1016/j.socscimed.2021.114414

 

Kellerborg, K., Brouwer, W., Versteegh, M., Wouterse, B., van Baal, P. (2022). Distributional consequences of including survivor costs in economic evaluations. Health Economics, 30(10), 2606-2613. DOI:10.1002/hec.4401

 

Hjalte, F., Norlin, J.M., Kellerborg, K., Odin, P. (2021). Parkinson's disease in Sweden-resource use and costs by severity. Acta Neurologica Scandinavia, 144(5), 592–599. DOI: 10.1111/ane.13502

 

Norlin, J.M., Kellerborg, K., Odin, P. (2021). Patient Utilities in Health States Based on Hoehn and Yahr and Off-Time in Parkinson's Disease: A Swedish Register-Based Study in 1823 Observations.

PharmacoEconomics, 39(10), 1141–1149. DOI: 10.1007/s40273-021-01056-z

 

Willis, M., Nilsson, A., Kellerborg, K., Ball, P., Roe, R., Traina, S., Beale, R., Newell, I. (2021). Cost-Effectiveness of Canagliflozin Added to Standard of Care for Treating Diabetic Kidney Disease (DKD) in Patients with Type 2 Diabetes Mellitus (T2DM) in England: Estimates Using the CREDEM-DKD Model.  Diabetes therapy : research, treatment and education of diabetes and related disorders, 12(1), 313–328. DOI: 10.1007/s13300-020-00968-x

 

de Vries, L. M., Kellerborg, K.M., Brouwer, W. B. F., & van Baal, P. H. M. (2021). Don't forget about the future: The impact of including future costs on the cost-effectiveness of adult pneumococcal conjugate vaccination with PCV13 in the Netherlands. Vaccine, 39(29), 3834–3843. DOI: 10.1016/j.vaccine.2021.05.091

​

​Humphrey, M., Larrouy-Maumus, G. J., Furniss, R. C. D., Mavridou, D. A. I., Sabnis, A., & Edwards, A. M. (2021). Colistin resistance in Escherichia coli confers protection of the cytoplasmic but not outer membrane from the polymyxin antibiotic. Microbiology (Reading, England), 167(11), 001104. DOI: 10.1099/mic.0.001104 

​

Nolan, L. M., Cain, A. K., Clamens, T., Furniss, R. C. D., Manoli, E., Sainz-Polo, M. A., Dougan, G., Albesa-Jové, D., Parkhill, J., Mavridou, D. A. I., & Filloux, A. (2021). Identification of Tse8 as a Type VI secretion system toxin from Pseudomonas aeruginosa that targets the bacterial transamidosome to inhibit protein synthesis in prey cells. Nature microbiology, 6(9), 1199–1210. DOI: 10.1038/s41564-021-00950-8

​

Howard, S. A., Furniss, R. C. D., Bonini, D., Amin, H., Paracuellos, P., Zlotkin, D., Costa, T. R. D., Levy, A., Mavridou, D. A. I., & Filloux, A. (2021). The Breadth and Molecular Basis of Hcp-Driven Type VI Secretion System Effector Delivery. mBio, 12(3), e0026221. DOI: 10.1128/mBio.00262-21

​​

Sabnis, A., Hagart, K. L., Klöckner, A., Becce, M., Evans, L. E., Furniss, R. C. D., Mavridou, D. A., Murphy, R., Stevens, M. M., Davies, J. C., Larrouy-Maumus, G. J., Clarke, T. B., & Edwards, A. M. (2021). Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane. eLife, 10, e65836. DOI: 10.7554/eLife.65836  

​

Bernal, P., Furniss, R. C. D., Fecht, S., Leung, R. C. Y., Spiga, L., Mavridou, D. A. I., & Filloux, A. (2021). A novel stabilization mechanism for the type VI secretion system sheath. Proceedings of the National Academy of Sciences of the United States of America, 118(7), e2008500118. DOI: 10.1073/pnas.2008500118
​

​

2020

​

Jonsson, E., Hansson-Hedblom, A., Kirketeig, T., Fritzell, P., Hägg, O., & Borgström, F. (2020). Cost and health outcomes patterns in patients treated with spinal cord stimulation following spine surgery—A register-based study. Neuromodulation: Technology at the Neural Interface, 23(5), 626-633.

​

Söreskog, E., Borgström, F., Shepstone, L., Clarke, S., Cooper, C., Harvey, I., ... & Kanis, J. A. (2020). Long-term cost-effectiveness of screening for fracture risk in a UK primary care setting: the SCOOP study. Osteoporosis International, 31, 1499-1506.

​

Söreskog, E., Ström, O., Spångéus, A., Åkesson, K. E., Borgström, F., Banefelt, J., ... & Charokopou, M. (2020). Risk of major osteoporotic fracture after first, second and third fracture in Swedish women aged 50 years and older. Bone, 134, 115286.

​

Ortsater, G., Banefelt, J., Soreskog, E., Timoshanko, J., Moayyeri, A., Akesson, K., ... & Libanati, C. (2020, November). Treat-to-Target in Osteoporosis: Total Hip BMD T-Score as an Indicator of Fracture Risk in Bisphosphonate-Treated Postmenopausal Women from Real-World Data. In JOURNAL OF BONE AND MINERAL RESEARCH (Vol. 35, pp. 215-215). 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY.​

​​

Kellerborg, K., Perry-Duxbury, M., de Vries, L., & van Baal, P. (2020). Practical Guidance for Including Future Costs in Economic Evaluations in The Netherlands: Introducing and Applying PAID 3.0. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 23(11), 1453–1461. DOI: 10.1016/j.jval.2020.07.004

 

Kellerborg, K., Brouwer, W., van Baal, P. (2020). Costs and benefits of interventions aimed at major infectious disease threats: lessons from the literature.

The European Journal of Health Economics, 21(9), 1329-1350. DOI: 0.1007/s10198-020-01218-4

 

Kellerborg, K., Brouwer, W., & van Baal, P. (2020). Costs and benefits of early response in the Ebola virus disease outbreak in Sierra Leone. Cost effectiveness and resource allocation : C/E, 18, 13. DOI: 10.1186/s12962-020-00207-x

​

Furniss, R. C. D., Kostrzewa, M., Mavridou, D. A. I., & Larrouy-Maumus, G. (2020). The clue is in the lipid A: Rapid detection of colistin resistance. PLoS pathogens, 16(4), e1008331. DOI: 10.1371/journal.ppat.1008331 

​​

2019

​

Hansson-Hedblom, A., Jonsson, E., Fritzell, P., Hägg, O., & Borgström, F. (2019). The association between patient reported outcomes of spinal surgery and societal costs: A register based study. Spine, 44(18), 1309-1317.

​

Smare, C., Venkatachalam, M., Medin, E., Hultberg, M., Penrod, J. R., Hertel, N., ... & Holmberg, C. (2019). An economic evaluation of nivolumab for the treatment of squamous and non-squamous NSCLC in the Swedish setting. Nordic Journal of Health Economics, 7(1), 47-64.

​​

Furniss, R. C. D., Dortet, L., Bolland, W., Drews, O., Sparbier, K., Bonnin, R. A., Filloux, A., Kostrzewa, M., Mavridou, D. A. I., & Larrouy-Maumus, G. (2019). Detection of Colistin Resistance in Escherichia coli by Use of the MALDI Biotyper Sirius Mass Spectrometry System. Journal of clinical microbiology, 57(12), e01427-19. DOI: 10.1128/JCM.01427-19 

​

2018

​

Olafsson, G., Jonsson, E., Fritzell, P., Hägg, O., & Borgström, F. (2018). Cost of low back pain: results from a national register study in Sweden. European Spine Journal, 27, 2875-2881.​​

​​​​

Furniss, R. C. D., Low, W. W., Mavridou, D. A. I., Dagley, L. F., Webb, A. I., Tate, E. W., & Clements, A. (2018). Plasma membrane profiling during enterohemorrhagic E. coli infection reveals that the metalloprotease StcE cleaves CD55 from host epithelial surfaces. The Journal of biological chemistry, 293(44), 17188–17199. DOI: 10.1074/jbc.RA118.005114  

​​

Dortet, L., Bonnin, R. A., Pennisi, I., Gauthier, L., Jousset, A. B., Dabos, L., Furniss, R. C. D., Mavridou, D. A. I., Bogaerts, P., Glupczynski, Y., Potron, A., Plesiat, P., Beyrouthy, R., Robin, F., Bonnet, R., Naas, T., Filloux, A., & Larrouy-Maumus, G. (2018). Rapid detection and discrimination of chromosome- and MCR-plasmid-mediated resistance to polymyxins by MALDI-TOF MS in Escherichia coli: the MALDIxin test. The Journal of antimicrobial chemotherapy, 73(12), 3359–3367. DOI: 10.1093/jac/dky330 

  

Shenoy, A. R., Furniss, R. C. D., Goddard, P. J., & Clements, A. (2018). Modulation of Host Cell Processes by T3SS Effectors. Current topics in microbiology and immunology, 416, 73–115. DOI: 10.1007/82_2018_106 

​

​

2017

​

Eriksson, D., Karlsson, L., Eklund, O., Dieperink, H., Honkanen, E., Melin, J., ... & Lundberg, J. (2017). Health-related quality of life across all stages of autosomal dominant polycystic kidney disease. Nephrology Dialysis Transplantation, 32(12), 2106-2111.

 

Eriksson, D., Karlsson, L., Eklund, O., Dieperink, H., Honkanen, E., Melin, J., ... & Lundberg, J. (2017). Real-world costs of autosomal dominant polycystic kidney disease in the Nordics. BMC Health Services Research, 17(1), 560

​

Olafsson, G., Jonsson, E., Fritzell, P., Hägg, O., & Borgström, F. (2017). A health economic lifetime treatment pathway model for low back pain in Sweden. Journal of Medical Economics, 20(12), 1281-1289. DOI: 10.1080/13696998.2017.1372252

​

Jonsson, E., Olafsson, G., Fritzell, P., Hägg, O., & Borgström, F. (2017). A profile of low back pain. Spine, 42(17), 1302-1310. DOI: 10.1097/brs.0000000000002089

​

Liang, F., Lindgren, G., Lin, A., Thompson, E. A., Ols, S., Röhss, J., ... & Loré, K. (2017). Efficient targeting and activation of antigen-presenting cells in vivo after modified mRNA vaccine administration in rhesus macaques. Molecular Therapy, 25(12), 2635-2647. ISO 690. DOI: 10.1016/j.ymthe.2017.08.006

​

Geale, K., Saridogan, E., Lehmann, M., Arriagada, P., Hultberg, M., & Henriksson, M. (2017). Repeated intermittent ulipristal acetate in the treatment of uterine fibroids: a cost-effectiveness analysis. ClinicoEconomics and Outcomes Research, 669-676. DOI: 10.2147/ceor.S143557

​

Jonsson, E., Olafsson, G., Fritzell, P., Hägg, O., & Borgström, F. (2017). A profile of low back pain. Spine, 42(17), 1302-1310.​

​

Alleweldt, F., Kara, S., Osinski, A., Van Baal, P., Kellerborg, K., Aarestrup, F. M., & Koopmans, M. (2017). Developing a framework to assess the costeffectiveness of COMPARE - a global platform for the exchange of sequence-based pathogen data. Revue scientifique et technique (International Office of Epizootics), 36(1), 311–322. DOI:10.20506/rst.36.1.2631

​

Furniss, R. C. D., & Clements, A. (2017). Regulation of the Locus of Enterocyte Effacement in Attaching and Effacing Pathogens. Journal of bacteriology, 200(2), e00336-17. DOI: 10.1128/JB.00336-17

​

Berger, C. N., Crepin, V. F., Roumeliotis, T. I., Wright, J. C., Carson, D., Pevsner-Fischer, M., Furniss, R. C. D., Dougan, G., Dori-Bachash, M., Yu, L., Clements, A., Collins, J. W., Elinav, E., Larrouy-Maumus, G. J., Choudhary, J. S., & Frankel, G. (2017). Citrobacter rodentium Subverts ATP Flux and Cholesterol Homeostasis in Intestinal Epithelial Cells In Vivo. Cell metabolism, 26(5), 738–752.e6. DOI: 10.1016/j.cmet.2017.09.003 

​

​​

​​​2016

​

Eklund, O., Afzal, F., Borgström, F., Flavin, J., Ternouth, A., Ojanguren, M. E., ... & Baldwin, M. (2016). Cost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe chronic obstructive pulmonary disease in Canada, Spain, Sweden, and the UK. ClinicoEconomics and Outcomes Research, 243-252.

 

Kellerborg, K., Danielsson, A. K., Allebeck, P., Coates, M. M., & Agardh, E. (2016). Disease burden attributed to alcohol: How methodological advances in the Global Burden of Disease 2013 study have changed the estimates in Sweden. Scandinavian journal of public health, 44(6), 604–610. DOI: 10.1177/1403494816653512

​

Furniss, R. C., Slater, S., Frankel, G., & Clements, A. (2016). Enterohaemorrhagic E. coli modulates an ARF6:Rab35 signaling axis to prevent recycling endosome maturation during infection. Journal of molecular biology, 428(17), 3399–3407. DOI: 10.1016/j.jmb.2016.05.023 

​

Rolhion, N., Furniss, R. C., Grabe, G., Ryan, A., Liu, M., Matthews, S. A., & Holden, D. W. (2016). Inhibition of Nuclear Transport of NF-ĸB p65 by the Salmonella Type III Secretion System Effector SpvD. PLoS pathogens, 12(5), e1005653. DOI:10.1371/journal.ppat.1005653 

​

​

​​​2015

​​

Eklund, O., Afzal, F., & Borgström, F. (2015). Cost-effectiveness of tiotropium versus usual care and glycopyrronium in the treatment of chronic obstructive pulmonary disease in Sweden. Cost Effectiveness and Resource Allocation, 13(1), 13.

​

Jonsson, E., Eriksson, D., Åkesson, K., Ljunggren, Ö., Salomonsson, S., Borgström, F., & Ström, O. (2015). Swedish osteoporosis care. Archives of osteoporosis, 10, 1-41. DOI: 10.1007/s11657-015-0222-7

​

Geale, K., Hultberg, M., & Henriksson, M. (2015). Applying symptom-based utility functions in health economic modelling: a case study of uterine fibroids. Value in Health, 18(7), A728. DOI: 10.1016/j.jval.2015.09.2772

​​​

​

2014​

​

​Clements, A., Stoneham, C. A., Furniss, R. C., & Frankel, G. (2014). Enterohaemorrhagic Escherichia coli inhibits recycling endosome function and trafficking of surface receptors. Cellular microbiology, 16(11), 1693–1705. DOI: 10.1111/cmi.12319 

​

2013

​

​Långström, N., Enebrink, P., Laurén, E. M., Lindblom, J., Werkö, S., & Hanson, R. K. (2013). Preventing sexual abusers of children from reoffending: systematic review of medical and psychological interventions. Bmj, 347. DOI: 10.1136/bmj.f4630​​

​

2012

​

By, A., Sobocki, P., Forsgren, A., & Silfverdal, S. A. (2012). Comparing health outcomes and costs of general vaccination with pneumococcal conjugate vaccines in Sweden: a Markov model. Clinical therapeutics, 34(1), 177-189. DOI: 10.1016/j.clinthera.2011.12.007​​​

​​​​

2010

​

​Mesterton, J., Wimo, A., By., A., Langworth, S., Winblad, B., & Jonsson, L. (2010). Cross sectional observational study on the societal costs of Alzheimer's disease. Current Alzheimer Research, 7(4), 358-367. DOI: 10.2174/156720510791162430

​

​

2009

​

Rosen, M., Axelsson, S., & Lindblom, J. (2009). When can RCTs and observational intervention studies mislead us and what can we do about it?. International journal of clinical practice, 63(11), 1562-1564. DOI: 10.1111/j.1742-1241.2009.02202.x

​

Alsiö, J., Birgner, C., Björkblom, L., Isaksson, P., Bergström, L., Schiöth, H. B., & Lindblom, J. (2009). Impact of nandrolone decanoate on gene expression in endocrine systems related to the adverse effects of anabolic androgenic steroids. Basic & clinical pharmacology & toxicology, 105(5), 307-314. DOI: 10.1111/j.1742-7843.2009.00439.x

​

Alsiö, J., Pickering, C., Roman, E., Hulting, A. L., Lindblom, J., & Schiöth, H. B. (2009). Motivation for sucrose in sated rats is predicted by low anxiety-like behavior. Neuroscience Letters, 454(3), 193-197. DOI: 10.1016/j.neulet.2009.03.045

​

Alsiö, J., Roman, E., Olszewski, P. K., Jonsson, P., Fredriksson, R., Levine, A. S., Meyerson, B.J.m Hulting, A-L., Lindblom, J., Schiöth, H. B. (2009). Inverse association of high‐fat diet preference and anxiety‐like behavior: a putative role for urocortin 2. Genes, Brain and Behavior, 8(2), 193-202. DOI: 10.1111/j.1601-183x.2008.00464.x

​

Rosén, M., Axelsson, S., & Lindblom, J. (2009). Observational studies versus RCTs: what about socioeconomic factors?. The Lancet, 373(9680), 2026. DOI: 10.1016/s0140-6736(09)61112-0

​

Erden, Z., von Krogh, G., Nytorp, C., & Hultberg, M. (2009). Strategic groups in the biopharmaceutical industry: implications for performance. Drug discovery today, 14(15-16), 726-730. DOI: 10.1016/j.drudis.2009.04.004

​

​

2008

​

Birgner, C., Kindlundh-Högberg, A. M., Oreland, L., Alsiö, J., Lindblom, J., Schiöth, H. B., & Bergström, L. (2008). Reduced activity of monoamine oxidase in the rat brain following repeated nandrolone decanoate administration. Brain research, 1219, 103-110. DOI: 10.1016/j.brainres.2008.05.014

​

Birgner, C., Kindlundh-Högberg, A. M., Alsiö, J., Lindblom, J., Schiöth, H. B., & Bergström, L. (2008). The anabolic androgenic steroid nandrolone decanoate affects mRNA expression of dopaminergic but not serotonergic receptors. Brain research, 1240, 221-228. DOI: 10.1016/j.brainres.2008.09.003

​

Fredriksson, R., Hägglund, M., Olszewski, P. K., Stephansson, O., Jacobsson, J. A., Olszewska, A. M., Stephansson, O., Jacobsson, J.A., Olszewska, A.M., Levine, A.S., Lindblom, J., Schiöth, H. B. (2008). The obesity gene, FTO, is of ancient origin, up-regulated during food deprivation and expressed in neurons of feeding-related nuclei of the brain. Endocrinology, 149(5), 2062-2071. DOI: 10.1210/en.2007-1457

​

Johansson, A., Fredriksson, R., Winnergren, S., Hulting, A. L., Schiöth, H. B., & Lindblom, J. (2008). The relative impact of chronic food restriction and acute food deprivation on plasma hormone levels and hypothalamic neuropeptide expression. Peptides, 29(9), 1588-1595. DOI: 10.1016/j.peptides.2008.04.018

​

​

2007

​

Pickering, C., Avesson, L., Lindblom, J., Liljequist, S., & Schiöth, H. B. (2007). Identification of neurotransmitter receptor genes involved in alcohol self-administration in the rat prefrontal cortex, hippocampus and amygdala. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 31(1), 53-64. DOI: 10.1016/j.pnpbp.2006.06.010

​

Jacobsson, J. A., Haitina, T., Lindblom, J., & Fredriksson, R. (2007). Identification of six putative human transporters with structural similarity to the drug transporter SLC22 family. Genomics, 90(5), 595-609. DOI: 10.1016/j.ygeno.2007.03.017

​

Pickering, C., Avesson, L., Liljequist, S., Lindblom, J., & Schiöth, H. B. (2007). The role of hypothalamic peptide gene expression in alcohol self-administration behavior. Peptides, 28(12), 2361-2371. DOI: 10.1016/j.peptides.2007.09.011

​

Pickering, C., Avesson, L., Lindblom, J., Liljequist, S., & Schiöth, H. B. (2007). To press or not to press? Differential receptor expression and response to novelty in rats learning an operant response for reward. Neurobiology of learning and memory, 87(2), 181-191. DOI: 10.1016/j.nlm.2006.08.005

​

​

2006

​

Haitina, T., Lindblom, J., Renström, T., & Fredriksson, R. (2006). Fourteen novel human members of mitochondrial solute carrier family 25 (SLC25) widely expressed in the central nervous system. Genomics, 88(6), 779-790. DOI: 10.1016/j.ygeno.2006.06.016

​

Lindblom, J., Johansson, A., Holmgren, A., Grandin, E., Nedergård, C., Fredriksson, R., & Schiöth, H. B. (2006). Increased mRNA levels of tyrosine hydroxylase and dopamine transporter in the VTA of male rats after chronic food restriction. European Journal of Neuroscience, 23(1), 180-186. DOI: 10.1111/j.1460-9568.2005.04531.x

​

von Knorring, L., Åkerblad, A. C., Bengtsson, F., Carlsson, Å., & Ekselius, L. (2006). Cost of depression: effect of adherence and treatment response. European psychiatry, 21(6), 349-354. DOI: 10.1016/j.eurpsy.2006.04.005

​

Borgström, F., Carlsson, Å., Sintonen, H., Boonen, S., Haentjens, P., Burge, R., ... & Kanis, J. A. (2006). The cost-effectiveness of risedronate in the treatment of osteoporosis: an international perspective. Osteoporosis international, 17, 996-1007. DOI: 10.1007/s00198-006-0094-1

​

​

2005

​

Lindblom, J., Haitina, T., Fredriksson, R., & Schiöth, H. B. (2005). Differential regulation of nuclear receptors, neuropeptides and peptide hormones in the hypothalamus and pituitary of food restricted rats. Molecular brain research, 133(1), 37-46. DOI: 10.1016/j.molbrainres.2004.09.025

​

Lindblom, J., Petrovska, R., Hallberg, M., Magnusson, K., Nyberg, F., & Uhlén, S. (2005). Nandrolone treatment decreases the α1B-adrenoceptor mRNA level in rat kidney, but not the density of α1B-adrenoceptors in cultured MDCK-D1 kidney cells. European journal of pharmacology, 527(1-3), 157-162. DOI: 10.1016/j.ejphar.2005.09.062

​

Höglund, P. J., Adzic, D., Scicluna, S. J., Lindblom, J., & Fredriksson, R. (2005). The repertoire of solute carriers of family 6: identification of new human and rodent genes. Biochemical and biophysical research communications, 336(1), 175-189. DOI: 10.1016/j.bbrc.2005.08.048

​

​

2004

​

Carlsson, Å., Borgström, F., Stålhammar, J., Alemao, E., Yin, D., & Jönsson, L. (2004). Cost of care for patients treated with lipid-lowering drugs. Pharmacoeconomics, 22, 25-35. DOI: 10.2165/00019053-200422003-00004

​

Kindlundh, A. M., Rahman, S., Lindblom, J., & Nyberg, F. (2004). Increased dopamine transporter density in the male rat brain following chronic nandrolone decanoate administration. Neuroscience letters, 356(2), 131-134. DOI: 10.1016/j.neulet.2003.11.040

​

Jansone, B., Bergstrom, L., Svirskis, S., Lindblom, J., Klusa, V., & Wikberg, J. E. (2004). Opposite effects of γ1-and γ2-melanocyte stimulating hormone on regulation of the dopaminergic mesolimbic system in rats. Neuroscience letters, 361(1-3), 68-71. DOI: 10.1016/j.neulet.2003.12.006

​

​

2003

​

Lindblom, J., Kindlundh, A. M., Nyberg, F., Bergström, L., & Wikberg, J. E. (2003). Anabolic androgenic steroid nandrolone decanoate reduces hypothalamic proopiomelanocortin mRNA levels. Brain research, 986(1-2), 139-147. DOI: 10.1016/s0006-8993(03)03223-2

​

Kindlundh, A. M., Lindblom, J., & Nyberg, F. (2003). Chronic administration with nandrolone decanoate induces alterations in the gene-transcript content of dopamine D1-and D2-receptors in the rat brain. Brain research, 979(1-2), 37-42. DOI: 10.1016/s0006-8993(03)02843-9

​

Kindlundh, A. M. S., Lindblom, J., Bergström, L., & Nyberg, F. (2003). The anabolic–androgenic steroid nandrolone induces alterations in the density of serotonergic 5HT1B and 5HT2 receptors in the male rat brain. Neuroscience, 119(1), 113-120. DOI: 10.1016/s0306-4522(03)00120-9

​

Uhlén, S., Lindblom, J., Kindlundh, A., Mugisha, P., & Nyberg, F. (2003). Nandrolone treatment decreases the level of rat kidney α 1B-adrenoceptors. Naunyn-Schmiedeberg's archives of pharmacology, 368, 91-98. DOI: 10.1007/s00210-003-0763-y

​

Lindqvist, N., Näpänkangas, U., Lindblom, J., & Hallböök, F. (2003). Proopiomelanocortin and melanocortin receptors in the adult rat retino-tectal system and their regulation after optic nerve transection. European journal of pharmacology, 482(1-3), 85-94. DOI: 10.1016/j.ejphar.2003.10.011

​

​

2002

​

Lindblom, J., Kask, A., Hägg, E., Härmark, L., Bergström, L., & Wikberg, J. (2002). Chronic infusion of a melanocortin receptor agonist modulates dopamine receptor binding in the rat brain. Pharmacological research, 45(2), 119-124. DOI: 10.1006/phrs.2001.0913

​

Lindblom, J., Wikberg, J. E. S., & Bergström, L. (2002). Alcohol-preferring AA rats show a derangement in their central melanocortin signalling system. Pharmacology Biochemistry and Behavior, 72(1-2), 491-496. DOI: 10.1016/s0091-3057(02)00719-0

​

​

2001

​

Lindblom, J., Opmane, B., Mutulis, F., Mutule, I., Petrovska, R., Klusa, V., ... & Wikberg, J. E. (2001). The MC4 receptor mediates α-MSH induced release of nucleus accumbens dopamine. Neuroreport, 12(10), 2155-2158. DOI: 10.1097/00001756-200107200-00022

​

Kindlundh, A. M., Lindblom, J., Bergström, L., Wikberg, J. E., & Nyberg, F. (2001). The anabolic‐androgenic steroid nandrolone decanoate affects the density of dopamine receptors in the male rat brain. European Journal of Neuroscience, 13(2), 291-296. DOI: 10.1046/j.0953-816x.2000.01402.x

​

​

2000

​

Wikberg, J. E., Muceniece, R., Mandrika, I., Prusis, P., Lindblom, J., Post, C., & Skottner, A. (2000). New aspects on the melanocortins and their receptors. Pharmacological research, 42(5), 393-420. DOI: 10.1006/phrs.2000.0725

​

Lindblom, J., Schiöth, H. B., Watanobe, H., Suda, T., Wikberg, J. E., & Bergström, L. (2000). Downregulation of melanocortin receptors in brain areas involved in food intake and reward mechanisms in obese (OLETF) rats. Brain research, 852(1), 180-185. DOI: 10.1016/s0006-8993(99)02125-3

​

​

1998

​

Lindblom, J., Schiöth, H. B., Larsson, A., Wikberg, J. E., & Bergström, L. (1998). Autoradiographic discrimination of melanocortin receptors indicates that the MC3 subtype dominates in the medial rat brain. Brain research, 810(1-2), 161-171. DOI: 10.1016/s0006-8993(98)00918-4

​

​

1997

​

Uhlén, S., Lindblom, J., Johnson, A., & Wikberg, J. E. (1997). Autoradiographic studies of central α2A-and α2C-adrenoceptors in the rat using [3H] MK912 and subtype-selective drugs. Brain research, 770(1-2), 261-266. DOI: 10.1016/s0006-8993(97)00860-3

​

Uhlen, S., Lindblom, J., Tiger, G., & Wikberg, J. E. S. (1997). Quantification of α2A and α2C adrenoceptors in the rat striatum and in different regions of the spinal cord. Acta physiologica scandinavica, 160(4), 407-412. DOI: 10.1046/j.1365-201x.1997.00175.x